Skip to main content
$0.50 $0.01 (1.6%)

12:41 PM EDT on 10/27/21

Advaxis Inc (NASDAQ:ADXS)

CAPS Rating: No stars

Current Price $0.50 Mkt Cap $72.0M
Open $0.50 P/E Ratio 0.00
Prev. Close $0.49 Div. (Yield) $0.00 (0.0%)
Daily Range $0.49 - $0.53 Volume 5,764,961
52-Wk Range $0.26 - $1.57 Avg. Daily Vol. 7,790,170

Caps

How do you think NASDAQ:ADXS will perform against the market?

Add Stock to CAPS Watchlist

All Players

40 Outperform
12 Underperform
 

All-Star Players

1 Outperform
4 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ADXS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

GorGecko99 (38.23)
Submitted May 22, 2016

Leader in immunotherapy research. Great long-term potential.

zzlangerhans (99.02)
Submitted October 09, 2015

Advaxis has pulled off the surprising feat of not only recovering all the ground lost on the after hours plunge on Tuesday after announcement of the ADXS-HPV clinical hold, but they've actually gained ground from before the hold was announced. And… More

NASDAQ:ADXS VS S&P 500 (SPY)

Fools bullish on NASDAQ:ADXS are also bullish on:

Fools bearish on NASDAQ:ADXS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ADXS.

Recs

1
Member Avatar GorGecko99 (38.23) Submitted: 5/22/2016 11:58:23 AM : Outperform Start Price: $118.80 NASDAQ:ADXS Score: -221.47

Leader in immunotherapy research. Great long-term potential.

Recs

1
Member Avatar Beststocks99 (35.23) Submitted: 5/22/2016 11:48:16 AM : Outperform Start Price: $118.80 NASDAQ:ADXS Score: -221.47

Recent insider analyst said this stock has massive potential on upside.

Recs

0
Member Avatar biotechf (73.84) Submitted: 4/9/2015 7:00:31 AM : Outperform Start Price: $271.50 NASDAQ:ADXS Score: -219.29

Immuotherapy cancer stock with recent announcement of positive clinical trial results in which all 10 patients showed a very good clinical outcome. It is still early in the clinical trial process but the ADXS has partnered with Big Pharma and in my opinion will receive an FDA breakthrough therapy designation soon. The company's market capitalization is small compared to its peers and I believe it will continue to catch up and reach $1 billion.

Leaderboard

Find the members with the highest scoring picks in ADXS.

Score Leader

TheSlightEdge

TheSlightEdge (98.68) Score: +447.64

The Score Leader is the player with the highest score across all their picks in ADXS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
NobleOrSomeBull 96.25 2/9/2016 Underperform 5Y $82.20 -99.39% +146.37% +245.76 0 Comment
MMCapitalMgmt 99.93 8/21/2014 Underperform 5Y $45.30 -98.89% +128.47% +227.36 0 Comment
ziggystraw 44.64 1/9/2015 Underperform 5Y $152.10 -99.67% +122.99% +222.66 0 Comment
Zencyclone 28.32 3/16/2015 Underperform 5Y $210.75 -99.76% +119.52% +219.28 0 Comment
km00nster 77.73 6/9/2015 Underperform 5Y $401.25 -99.87% +118.77% +218.65 0 Comment
vaipalolo 88.55 6/15/2015 Underperform 1Y $345.00 -99.85% +118.57% +218.43 0 Comment
SimonSaysSell 97.81 12/29/2014 Underperform NS $134.52 -99.63% +118.45% +218.07 0 Comment
Iwannabeadored 44.36 4/20/2015 Underperform 5Y $279.75 -99.82% +118.13% +217.95 0 Comment
Clint35 67.42 5/1/2015 Underperform NS $256.80 -99.80% +117.78% +217.58 0 Comment
OptimistPrime2 51.85 3/5/2015 Underperform 5Y $162.75 -99.69% +116.80% +216.49 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ADXS.